ChemBK
Home
Product Category
Suppliers
Search
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
(3R,4R,5R)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
CAS: 1402431-91-7
Molecular Formula: C16H28N2O4
Home
Product Category
pharmaceutical intermediates
API intermediate
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate -
Names and Identifiers
Name
(3R,4R,5R)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
Synonyms
Oseltamivir Impurity466
Oseltamivir Diastereomer IV HCl
Oseltamivir diastereomer IV hydrochloride
(3R,4R,5R)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
(3R,4R,5R)-ethyl4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylatephosphate
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5R)-
CAS
1402431-91-7
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate -
Physico-chemical Properties
Molecular Formula
C16H28N2O4
Molar Mass
312.4
Density
1.08±0.1 g/cm3(Predicted)
Boling Point
473.3±45.0 °C(Predicted)
pKa
14.68±0.70(Predicted)
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate -
Nature
acidity coefficient (pKa)
14.68±0.70(Predicted)
Last Update:2024-04-10 22:29:15
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate structural formula
Supplier List
View History
ethyl (3R,4R,5R)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
(±)-1,2,3,4,5,6,7,8-octahydro-1-[(4-methoxyphenyl)methyl]-2-methylisoquinoline
3',4',7,8-四羟基黄酮
2,6-二氯-9H-嘌呤核苷
肉豆蔻酸乙烯酯(含稳定剂MEHQ)
2409844-37-5
2-苯基-2-(对甲苯基)乙-1-胺盐酸盐
4-(3-FORMYL-4-HYDROXYPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
1079821-35-4
N-(3-氯丙基)二丁基胺(决奈达隆中间体)
Home
Product Category
© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001